We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
Cap. Flow
-$362M
Cap. Flow %
-1.06%
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$283M
2
MDT icon
Medtronic
MDT
+$96M
3
PM icon
Philip Morris
PM
+$80.4M
4
UPS icon
United Parcel Service
UPS
+$75.5M
5
D icon
Dominion Energy
D
+$74.2M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$178M
2
GIS icon
General Mills
GIS
+$158M
3
XOM icon
ExxonMobil
XOM
+$138M
4
NOW icon
ServiceNow
NOW
+$96M
5
KEYS icon
Keysight
KEYS
+$72.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.14%
2 Financials 15.14%
3 Technology 13.55%
4 Consumer Discretionary 8.1%
5 Consumer Staples 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTY
1951
DELISTED
Party City Holdco Inc.
PRTY
$3K ﹤0.01%
1,675
+466
+39% +$782
ARC
1952
DELISTED
ARC Document Solutions, Inc.
ARC
$3K ﹤0.01%
1,312
-112
-8% -$311
AAOI icon
1953
Applied Optoelectronics
AAOI
$8.09B
$2K ﹤0.01%
769
-5
-0.6% -$11
ACAD icon
1954
Acadia Pharmaceuticals
ACAD
$4.61B
$2K ﹤0.01%
139
-7,447
-98% -$121K
ALGS icon
1955
Aligos Therapeutics
ALGS
$31.2M
$2K ﹤0.01%
+81
New +$2.69K
AMSC icon
1956
American Superconductor
AMSC
$1.34B
$2K ﹤0.01%
391
APRE icon
1957
Aprea Therapeutics
APRE
$9.43M
$2K ﹤0.01%
173
-12
-6% -$213
ASRT
1958
DELISTED
Assertio
ASRT
$2K ﹤0.01%
+66
New +$2.98K
AUPH icon
1959
Aurinia Pharmaceuticals
AUPH
$2.15B
$2K ﹤0.01%
307
-127,490
-100% -$1.1M
BE icon
1960
Bloom Energy
BE
$76.4B
$2K ﹤0.01%
+84
New +$1.89K
BKSY icon
1961
BlackSky Technology
BKSY
$875M
$2K ﹤0.01%
+145
New +$2.51K
CALC icon
1962
CalciMedica
CALC
$13.5M
$2K ﹤0.01%
34
EPC icon
1963
Edgewell Personal Care
EPC
$1.23B
$2K ﹤0.01%
46
+16
+53% +$624
ESSA
1964
DELISTED
ESSA Bancorp
ESSA
$2K ﹤0.01%
109
EVTC icon
1965
Evertec
EVTC
$1.69B
$2K ﹤0.01%
58
-569
-91% -$20K
FCBC icon
1966
First Community Bankshares
FCBC
$902M
$2K ﹤0.01%
51
HBM icon
1967
Hudbay
HBM
$11.2B
$2K ﹤0.01%
570
HSBC icon
1968
HSBC
HSBC
$350B
$2K ﹤0.01%
89
ING icon
1969
ING
ING
$105B
$2K ﹤0.01%
253
INTT icon
1970
inTEST
INTT
$137M
$2K ﹤0.01%
203
-320
-61% -$2.62K
KLIC icon
1971
Kulicke & Soffa
KLIC
$4.12B
$2K ﹤0.01%
34
-22,867
-100% -$1.01M
KPLT icon
1972
Katapult Holdings
KPLT
$784M
$2K ﹤0.01%
+74
New +$2.29K
LSF icon
1973
Laird Superfood
LSF
$43.3M
$2K ﹤0.01%
1,149
IMDX
1974
Insight Molecular Diagnostics
IMDX
$132M
$2K ﹤0.01%
+121
New +$2.1K
OIS icon
1975
Oil States International
OIS
$519M
$2K ﹤0.01%
499
-626
-56% -$2.99K

Similar funds

Federated Hermes's Q3 2022 Portfolio in Review

As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.

  • Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
  • Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
  • Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
  • Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
  • Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
  • Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.

Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.